A.I. Virtanen Institute for Molecular Sciences - News

The doctoral thesis of Olli-Pekka Hätinen, MSc, provides crucial information about one potential gene therapy candidate for cardiac diseases, VEGF-B, and highlights issues that must be taken into consideration when developing new therapies.

Academy Professor Seppo Ylä-Herttuala at UEF is working together with scientists from Helsinki to develop a COVID-19 vaccine that will make use of gene transfer technology that has been developed in Kuopio.

The ERC Advanced Grant is highly competitive, making it one of the most esteemed grants in Europe.

The doctoral dissertation of Dilyara Nurkhametova, MD, provides a novel view on the involvement of local and systemic inflammatory processes in migraine, which were previously little studied in this disorder.

The pipeline described in the the PhD thesis by Anssi Lipponen, MSc, provides a rational stepwise procedure for evaluating the effects of systems-biology–discovered compounds to be repurposed for TBI and to accelerate discovery of drugs for TBI.